Wealthfront’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q4
Sell
-109
Closed -$6K 713
2015
Q3
$6K Buy
109
+82
+304% +$4.51K ﹤0.01% 1076
2015
Q2
$2K Buy
+27
New +$2K ﹤0.01% 1183